TABLE 2.

SARS-CoV-2 positivity distribution by reference method or Veritor SARS-CoV-2/Flu across all age groups

Age group	N (%)	Reference, n (%)	Veritor SARS-CoV-2/flu, n (%)
Without D site
18−21 yrs	8 (3.5)	5 (10.6)	4 (9.1)
22−49 yrs	127 (55.0)	26 (55.3)	23 (52.3)
50−59 yrs	53 (22.9)	6 (12.8)	7 (15.9)
60−69 yrs	32 (13.9)	6 (12.8)	6 (13.6)
70−79 yrs	8 (3.5)	3 (6.4)	3 (6.8)
≥80 yrs	3 (1.3)	1 (2.1)	1 (2.3)
Overall	231 (100)	47 (100)	44 (100)
All sites
18−21 yrs	10 (3.6)	5 (8.3)	4 (7.5)
22−49 yrs	147 (52.9)	31 (51.7)	25 (47.2)
50−59 yrs	63 (22.7)	10 (16.7)	11 (20.8)
60−69 yrs	42 (15.1)	7 (11.7)	7 (13.2)
70−79 yrs	13 (4.7)	6 (10.0)	5 (9.4)
≥80 yrs	3 (1.1)	1 (1.7)	1 (1.9)
Overall	278 (100)	60 (100)	53 (100)